Yes these all have had a very significant impact on moving towards approval * Purchase of Flaskworks for full automation and a 10X or more volume manufacturing improvement * Selling the site in England to help fund the company without another toxic stock sale * Change the end points to leverage historical data before lockdown which enable them to continue to pursue approval with this trial